Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-invasive ventilation support during feeding tube placement in amyotrophic lateral sclerosis patients with moderate to severe ventilatory impairment: an update.

Panminerva medica·2026
Same author

Continuous Ventilatory Support Without Hospitalization or Tracheotomies: A Retrospective Observational Study of Two Centers' Outcomes for Duchenne Muscular Dystrophy.

American journal of physical medicine & rehabilitation·2025
Same author

Dr Augusta Strongman Alba 1924-2024, Homage to a PM&R Legend.

American journal of physical medicine & rehabilitation·2025
Same author

Details Matter: The Difference Between NIV and NVS.

Muscle & nerve·2025
Same author

Dr. Augusta Strongman Alba 1924-2024, Homage to a PM&R.

American journal of physical medicine & rehabilitation·2025
Same author

Comparison of the Consequences of Short- Versus Long-Term Intubation on Speech and Swallowing.

American journal of physical medicine & rehabilitation·2024

Related Experiment Video

Updated: Jul 15, 2026

Extended 78% Hepatectomy in a Mouse Surgical Model
05:25

Extended 78% Hepatectomy in a Mouse Surgical Model

Published on: May 24, 2024

Long-term survival in Werdnig-Hoffmann disease.

John R Bach1, Katherine Saltstein, Diane Sinquee

  • 1Department of Physical Medicine amd Rehabilitation, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ 07871, USA.

American Journal of Physical Medicine & Rehabilitation
|April 24, 2007
PubMed
Summary

Spinal muscular atrophy type 1 (SMA 1) patients managed with noninvasive ventilation (NIV) or tracheostomy show prolonged survival. NIV offers better outcomes, with fewer hospitalizations and preserved speech ability compared to tracheostomy.

More Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

Related Experiment Videos

Last Updated: Jul 15, 2026

Extended 78% Hepatectomy in a Mouse Surgical Model
05:25

Extended 78% Hepatectomy in a Mouse Surgical Model

Published on: May 24, 2024

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

Area of Science:

  • Neurology
  • Pediatrics
  • Respiratory Medicine

Background:

  • Spinal muscular atrophy type 1 (SMA 1) is a severe genetic neuromuscular disorder.
  • Respiratory failure is the primary cause of mortality in SMA 1 patients.
  • Long-term outcomes regarding survival, speech, and ventilator dependence in SMA 1 are critical.

Purpose of the Study:

  • To evaluate long-term survival rates in SMA 1 patients.
  • To assess the impact of different ventilator management strategies on speech and ventilator dependence.
  • To compare outcomes between untreated, tracheostomy-managed, and noninvasively managed SMA 1 patients.

Main Methods:

  • Retrospective chart review of 106 SMA 1 patients.
  • Analysis of 92 severe SMA 1 cases categorized into three groups: untreated, tracheostomy, and noninvasive mechanical ventilation (NIV).
  • Comparison of survival age, speech development, and ventilator dependence across groups.

Main Results:

  • Untreated SMA 1 patients died around 9.6 months.
  • Tracheostomy management (group 2) resulted in a mean survival of 70.5 months, but led to continuous ventilator dependence and loss of speech in most.
  • Noninvasive ventilation (NIV) management (group 3) showed comparable survival to tracheostomy but with significantly fewer hospitalizations and preserved verbal communication in a majority of patients.

Conclusions:

  • Both NIV and tracheostomy can extend survival for SMA 1 patients.
  • NIV is associated with better functional outcomes, including preserved speech and reduced hospitalizations, compared to tracheostomy.
  • Tracheostomy management in SMA 1 leads to continuous ventilator dependence and hinders speech development.